| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 65.255 | 255.479 | 303.774 | 319.242 | 256.975 | 457.144 | 435.163 |
| Total Income - EUR | - | - | - | 65.255 | 255.518 | 308.203 | 319.242 | 257.046 | 457.195 | 436.805 |
| Total Expenses - EUR | - | - | - | 810 | 204.171 | 262.940 | 266.110 | 252.114 | 296.954 | 412.897 |
| Gross Profit/Loss - EUR | - | - | - | 64.445 | 51.347 | 45.263 | 53.132 | 4.933 | 160.241 | 23.908 |
| Net Profit/Loss - EUR | - | - | - | 62.487 | 48.067 | 43.153 | 50.045 | 2.737 | 155.880 | 15.449 |
| Employees | - | - | - | 0 | 8 | 8 | 7 | 8 | 9 | 6 |
Check the financial reports for the company - Pavdoser Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 9.175 | 14.422 | 439.434 | 3.624 | 2.422 | 22.308 |
| Current Assets | - | - | - | 63.517 | 68.360 | 41.687 | 52.967 | 90.504 | 189.448 | 109.564 |
| Inventories | - | - | - | 172 | 3.719 | 240 | 1.223 | 21.470 | 348 | 8.404 |
| Receivables | - | - | - | 39.594 | 59.742 | 34.759 | 45.947 | 58.366 | 179.109 | 62.780 |
| Cash | - | - | - | 23.751 | 4.899 | 6.688 | 5.796 | 10.668 | 9.991 | 38.379 |
| Shareholders Funds | - | - | - | 62.525 | 48.114 | 43.156 | 49.160 | 6.109 | 156.480 | 15.801 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 992 | 29.421 | 12.952 | 443.241 | 88.019 | 35.390 | 116.071 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Pavdoser Clinique S.r.l.